Copper metabolism

Reading File

Finding Sources

Searching PubMed

"copper metabolism" homeostasis

Reading File

Finding Sources

Reading File

Loading Image

I now have comprehensive, well-illustrated content from multiple authoritative textbooks. Here is the full answer:

Copper Metabolism

Overview

Copper (Cu) is an essential trace element that is simultaneously indispensable for life and toxic in excess. Dietary intake typically ranges from 1.5-4 mg/day, and the body maintains tight homeostasis through coordinated absorption, transport, intracellular chaperoning, and biliary excretion.

1. Dietary Sources and Absorption

Sources: Shellfish, liver, nuts, legumes, bran, organ meats.

Absorption occurs mainly in the proximal small intestine (stomach and duodenum). At the enterocyte brush border, the copper transporter CTR1 (SLC31A1) mediates uptake of Cu²⁺ after it is reduced to Cu⁺. Inside the enterocyte, the P-type ATPase ATP7A pumps copper across the basolateral membrane into the portal circulation. This step is the site of defect in Menkes disease (X-linked; ATP7A mutation), leading to failure of copper export from intestinal cells and a state of systemic copper deficiency.

2. Plasma Transport

After absorption, copper is loosely bound to:

Albumin (primary carrier in portal blood)
Histidine
α₂-macroglobulin

Portal blood flow directs most copper to the liver. A very small fraction travels to peripheral tissues (brain, eyes, and cuproenzymes).

3. Hepatic Handling - The Central Hub

The liver is the primary organ of copper regulation. Inside hepatocytes:

Metallochaperones (low-molecular-weight proteins) receive free copper - copper is never truly "free" within a cell.
Key intracellular chaperones direct copper to specific destinations:
- CCS → delivers Cu to superoxide dismutase (SOD1) in the cytoplasm
- COX17 → delivers Cu to cytochrome c oxidase in the mitochondria
- ATOX1 → delivers Cu to ATP7B in the trans-Golgi network (TGN)
Metallothioneins and glutathione act as overflow buffers, binding excess copper in a non-toxic form.

ATP7B (Wilson ATPase)

The hepatocyte's key copper pump is ATP7B, a membrane-bound P₁-type ATPase (1443 amino acids, 160 kDa, encoded on chromosome 13q14). It has two principal functions:

Incorporation of copper into apoceruloplasmin → forms holo-ceruloplasmin, secreted into blood
Biliary excretion of copper (via lysosomes to bile canaliculi) - the main route of copper elimination

When intracellular copper rises, ATP7B traffics from the TGN toward the apical (bile canalicular) membrane to increase biliary export.

Fig. 1 - Simplified overview of copper transport pathways and genetic disorders

Copper metabolism pathway showing oral intake, intestinal absorption, liver processing, biliary excretion, and disease loci

Modified from Sleisenger and Fordtran's Gastrointestinal and Liver Disease

Fig. 2 - Hepatocyte copper handling and Wilson disease mechanism

Intracellular copper handling by hepatocyte: ATP7B at TGN loading ceruloplasmin and exporting via lysosomes to bile canaliculi; Wilson disease ATP7B mutations block both pathways

Robbins & Kumar Basic Pathology

4. Ceruloplasmin

An α₂-glycoprotein, MW 132 kDa, containing 6 copper atoms per molecule
Synthesized in the liver by copper loading onto apoceruloplasmin (via ATP7B)
90% of plasma copper is bound as an integral part of ceruloplasmin
Normal serum level: 200-400 mg/L in adults (rises to 300-500 mg/L in early childhood, then falls)
Acts as a ferroxidase (oxidizes Fe²⁺ → Fe³⁺ for loading onto transferrin) - hence copper deficiency can cause iron-deficiency-like anemia
Is an acute-phase reactant: levels rise with inflammation, pregnancy, and exogenous estrogen use

5. Excretion

Bile is the primary excretion route: 1-4 mg/day
Urine copper excretion is normally very small (<50 µg/day)
No regulated re-absorption mechanism exists; excess copper simply overloads the hepatic system

6. Essential Cuproenzymes

Enzyme	Function
Cytochrome c oxidase (Complex IV)	Mitochondrial electron transport, ATP synthesis
Superoxide dismutase (SOD1, SOD3)	Free radical scavenging
Ceruloplasmin (ferroxidase)	Iron mobilization
Lysyl oxidase	Elastin and collagen cross-linking
Tyrosinase	Melanin synthesis
Dopamine β-monooxygenase	Catecholamine synthesis (dopamine → norepinephrine)
DBH / PAM	Neurotransmitter processing

7. Disorders of Copper Metabolism

Wilson Disease (Hepatolenticular Degeneration)

Gene: ATP7B mutation (chromosome 13q14), autosomal recessive
Prevalence: ~1 in 30,000 (may be higher)
Mechanism: Failure of ATP7B to export copper into bile AND to incorporate it into ceruloplasmin → copper accumulates in hepatocytes → oxidative injury → cirrhosis; overflow copper deposits in brain (basal ganglia), corneas, kidneys, bones
Lab findings: Low serum ceruloplasmin (<20 mg/dL), low total serum copper, elevated free (non-ceruloplasmin) copper, elevated 24-hour urine copper (>100 µg/day), elevated hepatic copper (>250 µg/g dry weight - most sensitive)
Clinical: Liver disease (acute hepatitis, chronic hepatitis, cirrhosis, acute liver failure), neuropsychiatric symptoms, Kayser-Fleischer rings (green-brown copper deposits in Descemet membrane of cornea)
Treatment: Copper chelation (D-penicillamine, trientine), zinc supplementation (blocks intestinal absorption), liver transplant in fulminant cases

Menkes Disease (Kinky/Steely-Hair Disease)

Gene: ATP7A mutation (X chromosome), X-linked recessive
Mechanism: Failure of ATP7A to export copper from enterocytes → systemic copper deficiency despite normal/elevated mucosal copper
Clinical: Intellectual disability, hypotonia, seizures, kinky/steely hair (pili torti), vascular fragility (dissecting aneurysms), death usually by age 5
Lab: Hypocupremia, decreased ceruloplasmin

Aceruloplasminemia

Gene: Ceruloplasmin gene (chromosome 3), autosomal recessive
Mechanism: Loss of ferroxidase activity → iron overload in brain and viscera
Clinical: Mental deterioration, microcytic anemia, low serum iron and copper

Copper Deficiency

Rare in adults; occurs in: premature infants on milk diets, malabsorption syndromes, nephrotic syndrome, excess zinc supplementation (zinc competes with copper for intestinal absorption)
Presents as refractory microcytic anemia, neutropenia, neurologic dysfunction

Copper Toxicity

Usually accidental (ingestion of copper salts, storage in copper vessels)
Severe cases: nausea, vomiting, hemolysis, hepatic failure, renal failure, coma

8. Copper-Iron Crosstalk

Ceruloplasmin's ferroxidase activity links copper and iron metabolism: it oxidizes Fe²⁺ to Fe³⁺, enabling loading onto transferrin for systemic iron delivery. Copper deficiency therefore impairs iron mobilization from stores, producing an anemia that resembles iron deficiency but does not respond to iron therapy.

Recent Evidence Note

A 2024 systematic review (PMID 39267265) has characterized cuproptosis - a distinct copper-dependent cell death pathway involving copper accumulation in mitochondria, binding to lipoylated TCA cycle proteins, and proteotoxic stress - as a newly recognized mechanism with implications in cancer biology and neurodegeneration. This is an active area of research distinct from classical Wilson disease pathophysiology.

Sources: Sleisenger and Fordtran's Gastrointestinal and Liver Disease; Robbins & Kumar Basic Pathology; Harrison's Principles of Internal Medicine 22E; Medical Physiology (Boron & Boulpaep)

This is a shared conversation. Sign in to Orris to start your own chat.